RSL1D1 and colorectal carcinoma: Notably, RSL1D1 suppresses the deacetylation of RAN by competitively interacting with Sirt7, which inhibits the accumulation of nuclear STAT3 and the autophagic program and then promotes the proliferation, invasion, and metastasis of CRC.